Economic and clinical comparison of atypical depot antipsychotic drugs for treatment of chronic schizophrenia in the Czech Republic

Author： Einarson Thomas R.   Zilbershtein Roman   Skoupá Jana   Veselá Šárka   Garg Madhur   Hemels Michiel E. H.  

Publisher： Informa Healthcare

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.9, 2013-09, pp. : 1089-1095

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia*

By Edwards Natalie C.   Pesa Jacqueline   Meletiche Dennis M.   Engelhart Luella   Thompson Ann K.   Sherr Jay   Dirani Riad  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3341-3355

Informa Healthcare

Access to resources Recommend Favorite

The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly

By  

Current Drug Safety, Vol. 1, Iss. 3, 2006-08 ,pp. : 227-241

Bentham Science Publishers

Access to resources Recommend Favorite

Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data

By Rajagopalan Krithika  

Journal of Medical Economics, Vol. 16, Iss. 7, 2013-07 ,pp. : 951-961

Informa Healthcare

Access to resources Recommend Favorite

Motor side effects of atypical antipsychotic drugs

By Chang Victoria   Friedman Joseph H  

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 5, 2015-05 ,pp. : 243-258

John Wiley & Sons Inc

Access to resources Recommend Favorite